-
Under-fire Alonso says Real Madrid situation can 'change quickly'
-
Greek govt seeks to tackle farmer protests after Crete clashes
-
Zelensky meets pope, prepares revised plan on Russia war
-
EU launches antitrust probe into Google's data use for AI
-
Cambodia-Thailand clashes spread on border as toll rises
-
Billionaire Trump fan Babis returns to power as Czech prime minister
-
German exports tread water as US, China shipments fall
-
England fast bowler Wood out of Ashes tour with injury
-
South Korea's president begins move back to historic Blue House
-
SEA Games to open in Thailand with tightened security
-
Honduran presidential candidate decries vote 'theft' in race against Trump-backed rival
-
Owners fled after Indian nightclub blaze killed 25: police
-
CERN upbeat as China halts particle accelerator mega-project
-
2025 on track to tie second hottest year on record: EU monitor
-
Chile to vote for president as hard-right Kast tipped to win
-
Chargers edge reigning champions Eagles after defensive show
-
RSF says Israel killed highest number of journalists again this year
-
Suns, Spurs win in last tuneups for NBA Cup showdowns
-
Hay to debut for New Zealand as Blundell out of 2nd West Indies Test
-
World record winning streak sets up Morocco for AFCON challenge
-
All Blacks face France in first Test at new Christchurch stadium
-
Cambodia and Thailand clash at border as civilian toll rises
-
South Korea police raid e-commerce giant Coupang over data leak
-
Most markets track Wall St losses as jitters set in ahead of Fed
-
Kenya deploys more police officers to control Haiti's gangs
-
Somali TikToker deported from US for spy kidnapping may be innocent
-
Indian pride as Asiatic lions roar back
-
Australia quick Hazlewood ruled out of Ashes after injury setback
-
Rising living costs dim holiday sparkle for US households
-
Data centers: a view from the inside
-
Long-serving Russian envoy to North Korea dies
-
Reddit says Australia's under-16 social media ban 'legally erroneous'
-
10 reported hurt after big Japan quake, warning of more tremors
-
Jimmy Kimmel extends late night contract for a year
-
Trump says US will allow sale of Nvidia AI chips to China
-
NBA fines Magic's Bane $35,000 for hurling ball at Anunoby
-
Pulisic quick-fire double sends AC Milan top of Serie A
-
Man Utd back on track after Fernandes inspires Wolves rout
-
Syria's Sharaa vows to promote coexistence, one year after Assad's ousting
-
World stocks mostly lower as markets await Fed decision
-
Palmer misses Chelsea's Champions League clash with Atalanta
-
Trump says Europe heading in 'bad directions'
-
Benin hunts soldiers behind failed coup
-
Salah a 'disgrace' for Liverpool outburst: Carragher
-
Peace deal at risk as DR Congo, Burundi slam Rwanda and M23 advances
-
Feminists outraged at video of French first lady's outburst against activists
-
Suspect arrested in theft of Matisse artworks in Brazil: officials
-
Troubled Liverpool host Barnsley in FA Cup third round
-
Slot has 'no clue' whether rebel star Salah has played last Liverpool game
-
Liverpool boss Slot says Salah relationship not broken
US overdose capital Baltimore on long road to recovery
Carrying a bag filled with the overdose-reversing drug naloxone, Adam Trionfo roams the brick-lined streets of one of America's oldest port cities, Baltimore.
The 40-year-old and his small team visit neighborhoods considered "hot spots" for drug trafficking to hand out the precious antidote, sold under the brand name Narcan.
The easy-to-use nasal spray has become a key tool in the fight against the deadly US opioid crisis, claiming 750,000 lives between the late 1990s and 2022.
"Just over the past week, we distributed 200 Narcan kits," Trionfo, who oversees an addiction assistance program with the local branch of Catholic Charities, told AFP.
On their route, the team spots a man sprawled out amid a pile of rubbish in the corner of a stairwell. They hand him a box of Narcan and a brochure about their organization.
The man takes it with one hand, as he awkwardly hides a syringe behind his back.
Their last Narcan kit goes to another man, legs covered in brown scars, who is waiting near a dilapidated building.
These scenes are not uncommon in this East Coast city, which is located about 50 kilometers (31 miles) from Washington and is renowned for endemic crime.
Baltimore was the setting of the hit television series "The Wire" in the early 2000s, depicting its burgeoning drug scene from a variety of angles.
And last year, the New York Times dubbed the city the "American overdose capital."
Between 2018 and 2022, the drug-related mortality rate was nearly twice as high as in any other major American city. The leading killer: fentanyl.
- 'Tremendous efforts' -
Since the height of the opioid crisis in 2021, the outlook has improved in much of the country, including in Baltimore.
The number of fatal overdoses in the city plummeted by 35 percent last year, to 680 down from 1,043 in 2023.
The city's proactive policies, coupled with preventative work done by Catholic charities in Baltimore's communities have helped make a dent in the problem.
"We've had tremendous efforts throughout the city to get people into treatment, and then we've also had tremendous efforts in getting Naloxone out there," said Michael Fingerhood, head of addiction medicine at Johns Hopkins Bayview Medical Center.
Distributed broadly for about a decade, Narcan has worked like a "fire extinguisher," Fingerhood said.
In Baltimore, Narcan is now available everywhere: pharmacies, vending machines throughout the city, even in libraries.
- Funded by restitution -
The drop in mortality in Baltimore is also linked to the composition of the fentanyl being sold there, Fingerhood said.
"The drug supply has less potent fentanyl and has additives that are less likely to cause overdose."
Awareness of the risks associated with the powerful synthetic opioid has also grown among users, pushing them to be more "cautious," said Bakari Atiba, community engagement director at Charm City Care Connection.
The nonprofit assists addicts in Baltimore -- known as Charm City -- and recently received funding from a restitution program fueled by lawsuits against opioid manufacturers and distributors.
"I'm not saying people are going to stop using," Atiba said. "That's not even our goal."
"It's about meeting people where they are, making sure they're safe, making sure they're supported, and making sure they have pathways to recovery if they want it."
A.P.Maia--PC